SecBot SecBot
SECBOTREPLAY Home › Report › RDY

RDY · Dr

DR REDDYS LABORATORIES LTD · 6-K filed Aug 10, 2026 at 12:18 ET

At the news

NEUTRALIMPACT 2/10

6-K filed Aug 10, 2026 at 12:18 ET

Dr. Reddy's terminated a distribution and promotion agreement with Novartis India Limited (NIL) due to a change in NIL's controlling shareholding. The company will continue commercializing the affected brands until September 30, 2026. This is a routine operational update with no material financial impact disclosed.

  • Terminated agreement dated February 11, 2022 with Novartis India Limited for distribution and promotion of select brands in India.
  • Termination follows a change in controlling shareholding of Novartis India Limited.
  • Dr. Reddy's will continue to commercialize the brands until September 30, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access